The Effect of Post-Cesarean Section Acupressure on the Severity of Pain and First Mobilization Distance

NCT ID: NCT05311449

Last Updated: 2022-09-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

64 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-06-26

Study Completion Date

2022-07-22

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This randomized controlled trial evaluates the effect of acupressure application on cesareans' pain and the number of steps in the first mobilization. This study hypothesizes that acupressure reduces pain and improves number of steps.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Methods: In the study, 64 cesareans will randomly assigned to acupressure and placebo acupressure groups. To the acupressure group (n = 32), an average of 15 minutes will be applied to the LI4 (liver), P6 (pericardium) and the Sanyinjia points on the splenic meridian (SP6) located on the inner side of the lower leg, four fingers above the ankle and behind the tibia. In the placebo acupressure group (n = 32), the points 1.5 cm away from the LI4, P6 and SP6 points (four points in total) will be applied for an average of 15 minutes. The primary outcome of the research is the effect of acupressure on the pain of cesareans. The secondary outcome of the study is to determine the effect of acupressure on the number of steps. The pain will be collected before and 1 minute, 2nd and 4th hour after acupressure and placebo acupressure administration. The number of steps will be collected 4th hour after acupressure and placebo acupressure administration.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pain Mobilization

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Prospective, parallel, two-arm, randomized controlled clinical trial, double blind
Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

In the study, a researcher (T.Ç.Y.) will determine the acupressure and placebo points to be applied to women. However, the researcher (A.A.) who will apply acupressure and placebo acupressure be blinded without knowing whether these points are acupressure or placebo points. Participants will not know that they are in the acupressure or placebo group. Thus, the research will be carried out as a double-blind randomized controlled trial. When the research is completed, the data of the control and study groups (A or B) will be transferred to the computer environment by a researcher independent of the research, and the data will be analyzed by a statistician and the findings will be reported.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Acupressure Group (experimental)

The experimental group will be given acupressure.

Group Type EXPERIMENTAL

Acupressure

Intervention Type OTHER

The experimental group will start with LI4 points, and continue with P6 and SP6 points. The application will be carried out by determining the priority order of the points with the draw. Attention will be paid to the intensity and duration of the pressure deemed appropriate. Since the individuals' responses will differ, the stiffness and pressure will be adjusted according to the individual's sensitivity not to cause tissue damage. Before starting the application, around the area to be pressed for 20-30 seconds will be gently rubbed with palm. With the gentle rubbing of the surrounding tissue, the tension and tissue sensitivity in warming, relaxing and preparatory will be reduced, and the tissue will be relieved. After, the point determined will be pressed manually for 2 minutes.

Placebo Acupressure Group (control)

The placebo group will be given placebo acupressure.

Group Type PLACEBO_COMPARATOR

Plasebo acupressure

Intervention Type OTHER

In the control group, the application will start with the points 1.5 cm around the LI4, P6 and SP6 points. The application process will continue in the same way with acupressure group and the pressure intensity will be less.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Acupressure

The experimental group will start with LI4 points, and continue with P6 and SP6 points. The application will be carried out by determining the priority order of the points with the draw. Attention will be paid to the intensity and duration of the pressure deemed appropriate. Since the individuals' responses will differ, the stiffness and pressure will be adjusted according to the individual's sensitivity not to cause tissue damage. Before starting the application, around the area to be pressed for 20-30 seconds will be gently rubbed with palm. With the gentle rubbing of the surrounding tissue, the tension and tissue sensitivity in warming, relaxing and preparatory will be reduced, and the tissue will be relieved. After, the point determined will be pressed manually for 2 minutes.

Intervention Type OTHER

Plasebo acupressure

In the control group, the application will start with the points 1.5 cm around the LI4, P6 and SP6 points. The application process will continue in the same way with acupressure group and the pressure intensity will be less.

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Acupress Placebo Acupress

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Being conscious,
* The mother tongue is Turkish,
* To be oriented and cooperative,
* be between 18-45 years old,
* To voluntarily agree to participate in the study (signing the Informed Consent Form),
* Repeated cesarean section,
* Cesarean section under spinal anesthesia,
* Not having a risky pregnancy (preeclampsia, gestational diabetes etc.),
* No health problems of the fetus,
* To have given birth by cesarean section between 37-40 weeks,
* To be in the second hour of the postpartum period,
* Not receiving post-op patient-controlled analgesia,
* Not to have smoked or used alcohol during pregnancy,
* No complications in the mother and/or newborn after cesarean section,
* No sensitivity in the area where acupressure will be applied,
* Absence of any systemic or psychiatric diagnosis,
* Absence of active COVID-19 infection.

Exclusion Criteria

* Lack of consciousness,
* The mother tongue is not Turkish,
* Not oriented and cooperative,
* Not to be between the ages of 18-45,
* Refusal to voluntarily participate in the study (those who did not sign the Informed Consent Form),
* Normal birth or cesarean delivery under general anesthesia,
* Cesarean delivery due to the risk of deterioration of maternal or fetal health,
* Not having had a risky pregnancy (preeclampsia, gestational diabetes, etc.),
* Not giving birth outside 37-40 weeks and by cesarean section,
* Not in the second hour of the postpartum period,
* Receiving post-op patient-controlled analgesia,
* To have used cigarettes and alcohol during pregnancy,
* Sensitivity in the area where acupressure will be applied,
* Presence of any systemic or psychiatric diagnosis,
* Active COVID-19 infection.
Minimum Eligible Age

18 Years

Maximum Eligible Age

45 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Mersin University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Tugba CAM YANIK

Research Assistant

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Duygu VEFİKULUÇAY YILMAZ, Doctorate

Role: STUDY_DIRECTOR

Mersin University

Aslıhan AKSU, master

Role: PRINCIPAL_INVESTIGATOR

Mersin University

Filiz DEĞİRMENCİ, master

Role: PRINCIPAL_INVESTIGATOR

Mersin University

Gülay ALTUN UĞRAŞ, doctorate

Role: PRINCIPAL_INVESTIGATOR

Mersin University

Mürşide ÇEVİKOĞLU KILLI, doctorate

Role: PRINCIPAL_INVESTIGATOR

Mersin City Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Mersin University

Mersin, Yenişehir, Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

References

Explore related publications, articles, or registry entries linked to this study.

Chen Y, Xiang XY, Chin KHR, Gao J, Wu J, Lao L, Chen H. Acupressure for labor pain management: a systematic review and meta-analysis of randomized controlled trials. Acupunct Med. 2021 Aug;39(4):243-252. doi: 10.1177/0964528420946044. Epub 2020 Aug 18.

Reference Type BACKGROUND
PMID: 32811182 (View on PubMed)

Smith CA, Collins CT, Levett KM, Armour M, Dahlen HG, Tan AL, Mesgarpour B. Acupuncture or acupressure for pain management during labour. Cochrane Database Syst Rev. 2020 Feb 7;2(2):CD009232. doi: 10.1002/14651858.CD009232.pub2.

Reference Type RESULT
PMID: 32032444 (View on PubMed)

Akgun M, Boz I. The effects of acupressure on post-cesarean pain and analgesic consumption: a randomized single-blinded placebo-controlled study. Int J Qual Health Care. 2020 Nov 16;32(9):609-617. doi: 10.1093/intqhc/mzaa107.

Reference Type RESULT
PMID: 32877509 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Mersin Universit

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.